MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+101.57%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$669M
AUM Growth
+$669M
(+258%)
Cap. Flow
+$479M
Cap. Flow
% of AUM
71.55%
Top 10 Holdings %
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16
Top Buys
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
$67.5M |
| 2 |
T-Mobile US
TMUS
|
$32.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$24.9M |
| 4 |
DraftKings
DKNG
|
$20.8M |
| 5 |
Aptiv
APTV
|
$13.2M |
Top Sells
Sector Composition
| 1 | Healthcare | 32.46% |
| 2 | Consumer Discretionary | 20.31% |
| 3 | Communication Services | 8.34% |
| 4 | Technology | 8.26% |
| 5 | Financials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NKLA
1
DELISTED
Nikola Corporation Common Stock
NKLA
| $67.5M | 10.1% | +1,000,000 | New | +$67.5M |
|
|
2
T-Mobile US
TMUS
$284B
| $32.3M | 4.83% | +310,000 | New | +$32.3M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $24.9M | 3.73% | +40,000 | New | +$24.9M |
|
|
4
DraftKings
DKNG
$23.8B
| $20.8M | 3.11% | +625,000 | New | +$20.8M |
|
|
5
Aptiv
APTV
$17.3B
| $13.2M | 1.98% | +170,000 | New | +$13.2M |
|
6
RenaissanceRe
RNR
$11.4B
| $12M | 1.79% | +70,000 | New | +$12M |
|
7
Immatics
IMTX
$619M
| $10.8M | 1.61% | +684,524 | New | +$10.8M |
|
8
American Airlines Group
AAL
$8.82B
| $10.5M | 1.56% | +800,000 | New | +$10.5M |
|
9
Essent Group
ESNT
$6.18B
| $9.97M | 1.49% | +275,000 | New | +$9.97M |
|
10
PG&E
PCG
$33.6B
| $9.76M | 1.46% | +1,100,000 | New | +$9.76M |
|
11
BILL Holdings
BILL
$4.72B
| $9.54M | 1.43% | +105,718 | New | +$9.54M |
|
12
Royalty Pharma
RPRX
$15.6B
| $8.74M | 1.31% | +180,000 | New | +$8.74M |
|
13
Guardant Health
GH
$8.41B
| $8.11M | 1.21% | +100,000 | New | +$8.11M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $7.94M | 1.19% | +130,000 | New | +$7.94M |
|
|
CSII
15
DELISTED
Cardiovascular Systems, Inc.
CSII
| $7.89M | 1.18% | +250,000 | New | +$7.89M |
|
|
FREE
16
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $7.59M | 1.13% | +940,000 | New | +$7.59M |
|
17
JD.com
JD
$44.1B
| $7.52M | 1.12% | +125,000 | New | +$7.52M |
|
18
Boston Scientific
BSX
$156B
| $7.37M | 1.1% | +210,000 | New | +$7.37M |
|
19
NMI Holdings
NMIH
$3.05B
| $7.08M | 1.06% | +440,000 | New | +$7.08M |
|
|
LGVW.U
20
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
| $7.07M | 1.06% | +700,000 | New | +$7.07M |
|
21
Mersana Therapeutics
MRSN
$36.5M
| $7.02M | 1.05% | +300,000 | New | +$7.02M |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.93M | 1.04% | +110,000 | New | +$6.93M |
|
23
Invitation Homes
INVH
$19.2B
| $6.88M | 1.03% | +250,000 | New | +$6.88M |
|
24
Skillz
SKLZ
$135M
| $6.59M | 0.98% | +599,996 | New | +$6.59M |
|
25
Axon Enterprise
AXON
$58.7B
| $6.38M | 0.95% | +65,000 | New | +$6.38M |
|